Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer

Authors

  • Peter Nygren Department of Radiology, Oncology and Radiation Science, Section of Oncology, Uppsala University, Uppsala, Sweden
  • Rolf Larsson Department of Medical Sciences, Section of Clinical Pharmacology, Uppsala University, Uppsala, Sweden

DOI:

https://doi.org/10.3109/0284186X.2013.844359

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2014-03-01

How to Cite

Nygren, P., & Larsson, R. (2014). Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer. Acta Oncologica, 53(3), 427–428. https://doi.org/10.3109/0284186X.2013.844359

Issue

Vol. 53 No. 3 (2014): Acta Oncologica

Section

Articles